<DOC>
	<DOCNO>NCT00487591</DOCNO>
	<brief_summary>The primary objective study compare effect simvastatin plus Omacor simvastatin plus placebo lower non-high density lipoprotein cholesterol subject mixed dyslipidemia .</brief_summary>
	<brief_title>An Evaluation Simvastatin Plus Omacor Compared Simvastatin Plus Placebo Subjects With Mixed Dyslipidemia</brief_title>
	<detailed_description>This trial utilize randomize , double-blind , two-period crossover design . At Visit 4 ( Week 0 ) , 5-week diet lead-in/baseline period , subject meet entry criterion randomize one two double-blind treatment sequence , simvastatin/Omacor first simvastatin/placebo first . Each treatment period consist 6 week . After randomization , subject self-administer study drug day evening .</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Men woman , age 1879 inclusive Fasting , untreated nonhighdensity lipoprotein cholesterol ( nonHDLC level ATP III goal Fasting , untreated triglyceride ( TG ) level high high range Provide write informed consent authorization protect health information Pregnancy Use lipidaltering drug stop History certain cardiovascular condition cardiac surgery within prior 6 month Body mass index 40 kg per square meter Allergy sensitivity omega3 fatty acid statin drug Poorlycontrolled condition include diabetes , hypertension , thyroid disease Certain muscle , liver , kidney , lung gastrointestinal condition Certain medication Active cancer treat within prior 2 year ( except nonmelanoma skin cancer )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>cholesterol</keyword>
	<keyword>dyslipidemia</keyword>
	<keyword>omega 3</keyword>
</DOC>